Paper · 34412058
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
1 to 20 of 28
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31506303 | Nusinersen for Type 1 Spinal Muscular Atrophy: A Father's Perspective. | Pediatrics | 2019 | https://conductscience.org/library/papers/31506303 | PubMed |
| 2 | 17537961 | Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. | J Neurosci | 2007 | https://conductscience.org/library/papers/17537961 | PubMed |
| 3 | 8390996 | Evaluation of 2'-modified oligonucleotides containing 2'-deoxy gaps as antisense inhibitors of gene expression. | J Biol Chem | 1993 | https://conductscience.org/library/papers/8390996 | PubMed |
| 4 | 33531663 | Sodium channelopathies in neurodevelopmental disorders. | Nat Rev Neurosci | 2021 | https://conductscience.org/library/papers/33531663 | PubMed |
| 5 | 24784568 | Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primates. | J Pharmacol Exp Ther | 2014 | https://conductscience.org/library/papers/24784568 | PubMed |
| 6 | 25568300 | The phenotypic spectrum of SCN8A encephalopathy. | Neurology | 2015 | https://conductscience.org/library/papers/25568300 | PubMed |
| 7 | 33307321 | Children and young adults with spinal muscular atrophy treated with nusinersen. | Eur J Paediatr Neurol | 2021 | https://conductscience.org/library/papers/33307321 | PubMed |
| 8 | 28192393 | Nusinersen, an antisense oligonucleotide drug for spinal muscular atrophy. | Nat Neurosci | 2017 | https://conductscience.org/library/papers/28192393 | PubMed |
| 9 | 20624852 | Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model. | Genes Dev | 2010 | https://conductscience.org/library/papers/20624852 | PubMed |
| 10 | 31943325 | Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome. | Ann Neurol | 2020 | https://conductscience.org/library/papers/31943325 | PubMed |
| 11 | 9259265 | The survival motor neuron protein in spinal muscular atrophy. | Hum Mol Genet | 1997 | https://conductscience.org/library/papers/9259265 | PubMed |
| 12 | 9077498 | A collaborative study on the natural history of childhood and juvenile onset proximal spinal muscular atrophy (type II and III SMA): 569 patients. | J Neurol Sci | 1997 | https://conductscience.org/library/papers/9077498 | PubMed |
| 13 | 31036929 | Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index. | Nat Biotechnol | 2019 | https://conductscience.org/library/papers/31036929 | PubMed |
| 14 | 28244990 | The chemical evolution of oligonucleotide therapies of clinical utility. | Nat Biotechnol | 2017 | https://conductscience.org/library/papers/28244990 | PubMed |
| 15 | 9880552 | Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression. | J Biol Chem | 1999 | https://conductscience.org/library/papers/9880552 | PubMed |
| 16 | 21971427 | Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene / allele-specific silencing of mutant huntingtin. | Mol Ther | 2011 | https://conductscience.org/library/papers/21971427 | PubMed |
| 17 | 27939059 | Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. | Lancet | 2016 | https://conductscience.org/library/papers/27939059 | PubMed |
| 18 | 7813012 | Identification and characterization of a spinal muscular atrophy-determining gene. | Cell | 1995 | https://conductscience.org/library/papers/7813012 | PubMed |
| 19 | 29091557 | Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy. | N Engl J Med | 2017 | https://conductscience.org/library/papers/29091557 | PubMed |
| 20 | 21482919 | Spinal muscular atrophy: a timely review. | Arch Neurol | 2011 | https://conductscience.org/library/papers/21482919 | PubMed |
papers-2026-11-12-0.1.0
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/papers/v1/34412058/references